Apimeds Pharmaceuticals US
Business Services · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
100 Matawan Rd Ste 325, Matawan, New Jer...Phone Number
(848) 201-5010Website
www.apimedsus.comRevenue
-Stock Symbol
APUSIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Apimeds Pharmaceuticals US
Apimeds Pharmaceuticals US, Inc. is a clinical-stage biopharmaceutical company developing novel therapies derived from bee venom, including its lead candidate Apitox for treating osteoarthritis and inflammatory conditions. It focuses on advancing non-opioid pain treatments through clinical research and regulatory approval.Explore more
Apimeds Pharmaceuticals US Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Apimeds Pharmaceuticals US your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Apimeds Pharmaceuticals US recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Apimeds Pharmaceuticals US
Apimeds Pharmaceuticals US, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Apimeds Pharmaceuticals US is spiking on competitors!
Check if Apimeds Pharmaceuticals US has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Apimeds Pharmaceuticals US launches new products
Click to see if Apimeds Pharmaceuticals US had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Apimeds Pharmaceuticals US has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Apimeds Pharmaceuticals US is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Apimeds Pharmaceuticals US is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Apimeds Pharmaceuticals US.
Apimeds Pharmaceuticals US Tech Stack
A closer look at the technologies used by Apimeds Pharmaceuticals US
See more technologies
Most Recent Scoops
Lateral Move
Executive Move
Christopher Kim has transitioned from Chief Medical Officer to the role of Chief Scientific Officer.
Executive Moves, Lateral Move
New Hire
Executive Move
Executive Moves, New Hire
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Funding
Initial Public Offering (IPO)
Apimeds Pharmaceuticals US has secured $13.5 million in additional funding through its initial public offering (IPO) of 3.4 million company shares priced at $4 per unit.
IPO, Funding
Initial Public Offering (IPO)
Apimeds Pharmaceuticals US News & Media
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Apimeds Pharmaceuticals US
Sign Up For FreeTo access detailed company insights
Apimeds Pharmaceuticals US, Inc. is a clinical-stage biopharmaceutical company developing novel therapies derived from bee venom, including its lead candidate Apitox for treating osteoarthritis and inflammatory conditions. It focuses on advancing non-opioid pain treatments through clinical research and regulatory approval.... Read More
